Module 10: Treatment quality, stigma and discrimination - introduction

In this document:
 
 
Module goal:

To develop participants’ capacity to provide or advocate for inclusive, high quality services that are accessible to people affected by HCV who inject (or used to).

Learning objectives:

By the end of the module, participants will be able to:

  • Distinguish a range of factors that can hinder or enable PWID’ access to HCV testing and treatment
  • List cross-cutting ways in which different populations’ needs require special consideration
  • Summarise key sources of guidance that relate to HCV treatment for drug users
Topics covered:
  • Hepatitis C and stigma
  • Obstacles to the provision of HCV treatment and care
  • Good practice in integrated services
  • Obstacles to the uptake of HCV treatment and care
  • Guidelines on HCV treatment for drug users
Before the training:
  • Clarify whether the forthcoming EASL Clinical Practice Guidelines for “Management of Hepatitis C Virus Infection” have been published. If so, these are likely to supersede the information in Slide 10.11 and Slide 10.12.
Materials and resources required:
  • Computer/laptop and projector
  • Flipchart paper, stand and pens
Module time: approximately 90 minutes

Show and talk to Slide 10.1 (Treatment quality, stigma and discrimination) outlining the module:


index ¦ top ¦ next